GMAB
Genmab AS
34.60$
-3.2%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.23 | 0.51 | 0.53 | 2.56 | 1.64 | 2.08 | 9.76 | 3.37 | 5.93 | 11.20 | 12.02 | 1.89 | |
| 0.02 | 0.05 | 0.07 | 0.11 | 0.14 | 0.22 | 0.40 | 0.38 | 0.55 | 0.45 | 0.64 | 0.11 | |
| 0.05 | 0.06 | 0.09 | 0.12 | 0.15 | 0.23 | 0.30 | 0.47 | 0.67 | 0.89 | 1.12 | 0.20 | |
| – | 0.00 | -0.07 | 0.32 | 0.14 | 0.33 | 0.64 | -0.48 | -0.12 | – | – | – | |
| 0.07 | -0.44 | -1.29 | 0.44 | -1.02 | -1.91 | 0.46 | -1.17 | -2.92 | 2.07 | -2.47 | 0.36 | |
| 0.13 | 0.22 | 0.05 | 0.14 | 0.77 | 0.17 | 0.47 | 0.38 | 0.48 | 0.57 | 0.29 | 0.06 | |
| -1.77 | -0.79 | -1.64 | -1.08 | -2.86 | -3.12 | -3.57 | -1.46 | -4.18 | -1.94 | -15.33 | -9.01 | |
| – | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.17 | 0.20 | 0.42 | – | – | – | |
| – | 1.06 | -0.19 | 0.00 | -0.24 | -0.01 | -0.04 | -0.68 | -1.38 | -0.86 | -6.17 | -0.69 | |
| – | 0.00 | 0.00 | -0.05 | -0.05 | -0.05 | -0.07 | -0.09 | -0.11 | -0.02 | -0.01 | -0.02 | |
| 1.81 | 1.06 | 0.15 | 0.35 | -0.11 | 5.75 | 0.11 | -0.64 | -1.20 | -0.92 | -6.06 | 7.65 | |
| 0.33 | 0.85 | -0.92 | 1.68 | -1.31 | 4.74 | 5.63 | 2.57 | 1.42 | 7.55 | -7.75 | 0.55 | |
| 0.10 | 0.29 | 0.48 | 2.42 | 0.87 | 1.91 | 9.30 | 2.99 | 5.45 | 10.63 | 11.73 | 1.83 |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.